Download
s00392-020-01737-3.pdf 1,06MB
WeightNameValue
1000 Titel
  • Safety and effectiveness of coronary intravascular lithotripsy in eccentric calcified coronary lesions: a patient-level pooled analysis from the Disrupt CAD I and CAD II Studies
1000 Autor/in
  1. Blachutzik, Florian |
  2. Honton, Benjamin |
  3. Escaned, Javier |
  4. Hill, Jonathan M. |
  5. Werner, Nikos |
  6. Banning, Adrian P. |
  7. Lansky, Alexandra J. |
  8. Schlattner, Sophia |
  9. De Bruyne, Bernard |
  10. Di Mario, Carlo |
  11. Dörr, Oliver |
  12. Hamm, Christian |
  13. Nef, Holger M. |
1000 Verlag
  • Springer Berlin Heidelberg
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-09-18
1000 Erschienen in
1000 Quellenangabe
  • 110(2):228-236
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00392-020-01737-3 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862504/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>The aim of this study was to assess the safety and effectiveness of intravascular lithotripsy (IVL) in treating eccentric calcified coronary lesions.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Between December 2015 and March 2019, 180 patients were enrolled in the Disrupt CAD I and CAD II studies across 19 sites in 10 countries. Patient-level data were pooled from these two studies (<jats:italic>n</jats:italic> = 180), within which 47 eccentric lesions (26%) and 133 concentric lesions were identified.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>Clinical success, defined as residual stenosis &lt; 50% after stenting and no in-hospital MACE, was similar between the eccentric and concentric cohorts (93.6% vs. 93.2%,<jats:italic>p</jats:italic> = 1.0). There were no perforations, abrupt closure, slow flow or no reflow events observed in either group, and there were low rates of flow-limiting dissections (Grade D–F: 0% eccentric, 1.7% concentric;<jats:italic>p</jats:italic> = 0.54). Final acute gain and percent residual stenosis were similar between the two groups. Final residual stenosis of 8.6 ± 9.8% in eccentric and 10.0 ± 9.0% (<jats:italic>p</jats:italic> = 0.56) in concentric stenosis confirms the significant effect of IVL in calcified coronary lesions.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>In this first report from a pooled patient-level analysis of coronary IVL from the Disrupt CAD I and CAD II studies, IVL use was associated with consistent improvement in procedural and clinical outcomes in both eccentric and concentric calcified lesions.</jats:p></jats:sec>
1000 Sacherschließung
lokal Coronary Vessels/diagnostic imaging [MeSH]
lokal Female [MeSH]
lokal Coronary Stenosis/therapy [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Lithotripsy/methods [MeSH]
lokal Vascular Calcification/diagnosis [MeSH]
lokal Stents [MeSH]
lokal Aged [MeSH]
lokal Endovascular Procedures/methods [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Treatment Outcome [MeSH]
lokal Coronary Stenosis/etiology [MeSH]
lokal Vascular Calcification/complications [MeSH]
lokal Male [MeSH]
lokal Calcified lesions
lokal Coronary Angiography [MeSH]
lokal Vascular Calcification/surgery [MeSH]
lokal Original Paper
lokal Percutaneous coronary intervention
lokal Lithotripsy
lokal Coronary Stenosis/diagnosis [MeSH]
lokal Clinical research
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-7695-3663|https://frl.publisso.de/adhoc/uri/SG9udG9uLCBCZW5qYW1pbg==|https://frl.publisso.de/adhoc/uri/RXNjYW5lZCwgSmF2aWVy|https://frl.publisso.de/adhoc/uri/SGlsbCwgSm9uYXRoYW4gTS4=|https://frl.publisso.de/adhoc/uri/V2VybmVyLCBOaWtvcw==|https://frl.publisso.de/adhoc/uri/QmFubmluZywgQWRyaWFuIFAu|https://frl.publisso.de/adhoc/uri/TGFuc2t5LCBBbGV4YW5kcmEgSi4=|https://frl.publisso.de/adhoc/uri/U2NobGF0dG5lciwgU29waGlh|https://frl.publisso.de/adhoc/uri/RGUgQnJ1eW5lLCBCZXJuYXJk|https://frl.publisso.de/adhoc/uri/RGkgTWFyaW8sIENhcmxv|https://frl.publisso.de/adhoc/uri/RMO2cnIsIE9saXZlcg==|https://frl.publisso.de/adhoc/uri/SGFtbSwgQ2hyaXN0aWFu|https://frl.publisso.de/adhoc/uri/TmVmLCBIb2xnZXIgTS4=
1000 Hinweis
  • DeepGreen-ID: 82091c65a1cc45fc90fc61f61c120b6b ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Shockwave Medical Inc., Santa Clara, CA, USA |
  2. Justus-Liebig-Universität Gießen |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Shockwave Medical Inc., Santa Clara, CA, USA |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Justus-Liebig-Universität Gießen |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6469942.rdf
1000 Erstellt am 2023-11-18T02:46:07.051+0100
1000 Erstellt von 322
1000 beschreibt frl:6469942
1000 Bearbeitet von 317
1000 Zuletzt bearbeitet 2025-07-29T23:39:16.188+0200
1000 Objekt bearb. Tue Jul 29 23:39:16 CEST 2025
1000 Vgl. frl:6469942
1000 Oai Id
  1. oai:frl.publisso.de:frl:6469942 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source